Immunological effects and safe administration of alemtuzumab (MabCampath) in advanced B-cLL.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Peter Hillmen |
| Publication date | January 1, 2002 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |